Broker Tips
Broker tips: Hikma Pharmaceuticals, Imperial Brands, Pearson
Barclays upgraded Hikma Pharmaceuticals to 'overweight' and increased its price target on the company's shares after a US court ruled in favour of the generic drugmaker's treatment for heart conditions.
Deutsche Bank lifts Anglo American target price
Deutsche Bank upped its price target on Anglo American to 2,500p from 2,200p on Friday, keeping the rating at ‘buy’.
Morgan Stanley predicts Sunak will extend furlough scheme
Chancellor Rishi Sunak is likely to extend his furlough job support programme beyond October to avoid major economic scarring from a surge in unemployment, Morgan Stanley said.
Friday broker round-up
Imperial Brands: JP Morgan upgrades to overweight with a target price of 1,650. 0p.
Berenberg raises target price on ‘sell’ rated Pearson
Analysts at Berenberg raised their target price on media firm Pearson from 400. 0p to 450. 0p on Friday, but stated the group's incoming chief executive, Andy Bird, faced "material challenges".
Barclays upgrades Hikma after US court ruling
Barclays upgraded Hikma Pharmaceuticals to 'overweight' and increased its price target on the company's shares after a US court ruled in favour of the generic drugmaker's treatment for heart conditions.
JPMorgan upgrades Imperial Brands to 'overweight'
JPMorgan Cazenove upgraded its rating on shares of Imperial Brands on Friday to ‘overweight’ from ‘neutral’, as it said the current valuation is pricing in severe downside risks, leaving the risk/reward tilted strongly to the upside following the dividend cut in May.